BioSpace News Archive

Dr. Robbins brings 20 years of experience as an executive leading and advising innovative biotechnology companies through all stages of development.

Dicom Systems (www.dcmsys.com), a leader in Enterprise Imaging interoperability and workflow software, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent 10,437,877 B2 to support the company’s position as a healthcare and medical imaging software developer of solutions designed with interoperability and user-configuration at the forefront.

Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Steven Paladino, the Company’s Executive Vice President and Chief Financial Officer.

PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering development of multi-functional novel immunotherapies, today announced that it has completed manufacturing of clinical batches of PDS0101 with its partner BSP Pharmaceuticals S.p.A, a leading manufacturer of anticancer drugs.

Grady Memorial Hospital is the largest hospital in the state of Georgia and the fifth-largest public hospital in the United States.

Newly Allowed Patent Covers use of the CertainT ® Platform in Cellulosic Fibers and Materials including Rayon; Company Currently in Discussions with Leading Manufacturers

Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that it will be presenting at the Dawson James Securities 5th Annual Small Cap Growth Conference being held on October 28-29, 2019 at the Wyndham Grand Hotel in Jupiter, Florida.

Patients living in Quebec will now have access, through the Régie de l’assurance maladie Québec (RAMQ), to DUPIXENT™ (dupilumab).1 DUPIXENT™ is used to treat adult patients with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable

The program recognizes companies for outstanding efforts to implement quality workplace employee health programs.

Honorees recognized for groundbreaking efforts to accelerate scientific progress toward new treatments for neurodegenerative diseases